Device / Technology News

RSS

Affymetrix commences shipment of gene profiling reagents

Affymetrix, Inc. today began shipping its FDA-cleared Gene Profiling Reagents. Affymetrix also announced the availability of the new Gene Profiling Array cGMP U133 P2, a version of the widely cited Human Genome U133 Plus 2.0 Array, as another component to its GeneChip Instrument System, which is used by Affymetrix partners for assay development.

12 Jul 2011

Health IT could give seniors independence, consumers more control

In this pair of articles, news outlets report on how technology is playing a role in health care.

12 Jul 2011

Sevocity's EHR v11.1 achieves CCHIT 2011 certification

Sevocity, the leader in cloud-based Electronic Health Records, today announced that Sevocity v11.1 has achieved full certification through the Certification Commission for Health Information Technology (CCHIT) and is a CCHIT Certified 2011 Ambulatory EHR.

12 Jul 2011

Cardiologists still perform artery-opening procedure despite changes in guidelines

Despite changes in standard treatment practice guidelines issued by the American College of Cardiology, American Heart Association and the European Society of Cardiology several years ago, there has been no meaningful change in the nation's practice of opening completely blocked coronary arteries with balloons and stents in the days after a heart attack, according to a new study published in the July 11, 2011, issue of Archives of Internal Medicine.

12 Jul 2011

Battle lines drawn in the CT dose reduction arena

Over the past ten years, Computed Tomography (CT) vendors have been in a fierce race to capitalise on the trend for multi-slice CT equipment. However, in the last three years, increasing concerns over radiation exposure from CT examinations have driven a focus on dose-reduction, and CT product development has followed suit. As battle lines are drawn in the dose-reduction arena, InMedica (www.in-medica.com) analyses the competition for CT slices in its new report “The World Market for CT and PET-CT Equipment.” Importantly, what will this mean for dose-reduction?

12 Jul 2011

genOway acquires worldwide exclusive license for RMCE technology from bluebird bio for genetically modified rodents

genOway and bluebird bio report today genOway acquisition of an exclusive worldwide license for the RMCE technology (developed at the Massachusetts Institute of Technology) in the field of genetically modified rodents.

12 Jul 2011

FDA approves protocol for Medtronic's SYMPLICITY HTN-3 for treatment of hypertension

Medtronic, Inc., announced today that the U.S. Food and Drug Administration (FDA) has conditionally approved the protocol for SYMPLICITY HTN-3, the company's U.S. clinical trial of renal denervation with the Symplicity Catheter System for the treatment of resistant hypertension, an especially dangerous disease affecting hundreds of millions of people worldwide.

From Medtronic 12 Jul 2011

Toumaz announces JV for newly approved ‘digital plaster’

Toumaz Limited (AIM: TMZ,) has established a new joint venture with Dr. Patrick Soon-Shiong’s company California Capital Equity LLC (‘CCE’), to expand the commercialisation and distribution of the Sensium™ Digital Plaster. The joint venture, which is named “Toumaz US LLC”, will be headquartered in San Diego, California, and will sell and distribute the Sensium™ Digital Plaster in North America and Worldwide.

11 Jul 2011

Parallels, Microsoft partner to deliver complete cloud automation solution for health community

At the Microsoft World Wide Partner conference, Parallels today announced a two-year strategic relationship with Microsoft to deliver a complete cloud automation solution focused on meeting the needs of the health industry around the world.

11 Jul 2011

New method allows for concurrent treatment of spinal tumors and stabilization of the spine

The Orthopedic Clinic and Policlinic at the University Medical Center of Johannes Gutenberg University Mainz has recently deployed a new system for the treatment of spinal tumors for the first time.

11 Jul 2011

Microneedle patches may target dentritic cells more efficiently and induce immunity against HIV

Applying a vaccine patch to the skin with thousands of tiny micro-needles could help boost the body's immune response and prevent the spread of life-threatening infections like HIV and TB, a major Cardiff University study aims to uncover.

11 Jul 2011

CMC hospital Ludhiana upgrades to MLCi2-equipped Elekta Compact linear accelerator

Christian Medical College & Hospital (CMC) Ludhiana is the site of the first Elekta Compact™ linear accelerator in the world to be field-upgraded to an MLCi2-equipped Elekta Compact, completing the transformation in less than a week. MLCi2 shapes treatment beams, enabling doctors to provide more accurate delivery to the target, while limiting radiation exposure to surrounding structures.

From Elekta 11 Jul 2011

Research validates SpinalCyte's core technology to regrow the spinal disc

SpinalCyte, LLC, a spinal technology company focused on autologous regrowth of the spinal disc nucleus using human dermal fibroblasts, announced today the publication of its research completed with Rice University, titled, "Chondrogenic Differentiation of Neonatal Human Dermal Fibroblasts Encapsulated in Alginate Beads with Hydrostatic Compression Under Hypoxic Conditions in the Presence of Bone Morphogenetic Protein-2".

11 Jul 2011

FDA clears TearScience's LipiFlow Thermal Pulsation System for evaporative dry eye

TearScience, Inc., a privately-held medical device company, today announced that it has received U.S. Food and Drug Administration (FDA) clearance for its LipiFlow Thermal Pulsation System for the treatment of meibomian gland dysfunction (MGD), also known as evaporative dry eye.

11 Jul 2011

iBio successfully produces human plasma proteins using proprietary technology

iBio, Inc. today announced successful production of human plasma proteins using its proprietary iBioLaunch technology. Human alpha 1-antitrypsin and human C1 esterase inhibitor were successfully produced at high yield in green plants via the Company's proprietary iBioLaunch technology. Both of these proteins are important therapeutic products, but until now they have been made from human blood.

11 Jul 2011

Ion Torrent ships three next-generation sequencers

Ion Torrent, a unit of Life Technologies Corporation, today announced that it is shipping its new 100 Mb Ion 316 chip, which has tenfold more throughput than the original Ion 314 chip, and that its 1 Gb Ion 318 chip will be available in the fourth quarter.

11 Jul 2011

BGI, Covaris partner to provide next generation sequencing technology

BGI and Covaris, Inc. today announced a deal that will integrate Covaris' Adaptive Focused Acoustics AFA DNA shearing technology across several BGI laboratories in China.

11 Jul 2011

Endosense completes first patient case utilizing new prototype software

Endosense, a Swiss medical technology company, has announced completion of the first patient case utilizing prototype software that integrates the contact-force data provided by Endosense's TactiCath force-sensing ablation catheter with Siemens Healthcare's electrophysiology solutions.

11 Jul 2011

Illumina, Sequenom sign three-year supply agreement

Sequenom, Inc., a life sciences company providing innovative genetic analysis solutions, today announced it has signed a three-year supply agreement with Illumina, Inc., a leading developer and manufacturer of life sciences tools for the large-scale analysis of genetic variation and function.

From Illumina, Inc. 11 Jul 2011

USPTO issues notice of allowance to PROLOR Biotech's CTP platform

PROLOR Biotech, Inc., today announced that it has received a notice of allowance from the U.S. Patent and Trademark Office (PTO) for a patent application covering the company's CTP platform, which has the potential to extend the duration of activity of virtually all therapeutic proteins.

11 Jul 2011

Device / Technology News

Affymetrix commences shipment of gene profiling reagents

Health IT could give seniors independence, consumers more control

Sevocity's EHR v11.1 achieves CCHIT 2011 certification

Cardiologists still perform artery-opening procedure despite changes in guidelines

Battle lines drawn in the CT dose reduction arena

genOway acquires worldwide exclusive license for RMCE technology from bluebird bio for genetically modified rodents

FDA approves protocol for Medtronic's SYMPLICITY HTN-3 for treatment of hypertension

Toumaz announces JV for newly approved ‘digital plaster’

Parallels, Microsoft partner to deliver complete cloud automation solution for health community

New method allows for concurrent treatment of spinal tumors and stabilization of the spine

Microneedle patches may target dentritic cells more efficiently and induce immunity against HIV

CMC hospital Ludhiana upgrades to MLCi2-equipped Elekta Compact linear accelerator

Research validates SpinalCyte's core technology to regrow the spinal disc

FDA clears TearScience's LipiFlow Thermal Pulsation System for evaporative dry eye

iBio successfully produces human plasma proteins using proprietary technology

Ion Torrent ships three next-generation sequencers

BGI, Covaris partner to provide next generation sequencing technology

Endosense completes first patient case utilizing new prototype software

Illumina, Sequenom sign three-year supply agreement

USPTO issues notice of allowance to PROLOR Biotech's CTP platform

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News